Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 8
2015 8
2016 3
2017 6
2018 9
2019 16
2020 24
2021 28
2022 23
2023 19
2024 17
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Abdolreaza
Page 1
Did you mean abdolreza naser moghadasi (1 results)?
Gut microbiome in multiple sclerosis-related cognitive impairment.
Ghadiri F, Ebadi Z, Asadollahzadeh E, Naser Moghadasi A. Ghadiri F, et al. Among authors: naser moghadasi a. Mult Scler Relat Disord. 2022 Nov;67:104165. doi: 10.1016/j.msard.2022.104165. Epub 2022 Sep 7. Mult Scler Relat Disord. 2022. PMID: 36152393 Review.
Autoimmune encephalitis associated with COVID-19: A systematic review.
Nabizadeh F, Balabandian M, Sodeifian F, Rezaei N, Rostami MR, Naser Moghadasi A. Nabizadeh F, et al. Among authors: naser moghadasi a. Mult Scler Relat Disord. 2022 Jun;62:103795. doi: 10.1016/j.msard.2022.103795. Epub 2022 Apr 6. Mult Scler Relat Disord. 2022. PMID: 35472834 Free PMC article. Review.
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Sahraian MA, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, Baghbanian SM, Sedighi B, Naser Moghadasi A, Nahayati MA, Ghalyanchi Langroodi H, Mohammadianinejad SE, Beladi Moghadam N, Ayromlou H, Nikseresht A, Ghiasian M, Razazian N, Asadollahzadeh E, Sabzvari A, Kafi H, Albooyeh S. Sahraian MA, et al. Among authors: naser moghadasi a. Sci Rep. 2024 Oct 22;14(1):24921. doi: 10.1038/s41598-024-75745-y. Sci Rep. 2024. PMID: 39438591 Free PMC article. Clinical Trial.
Acupuncture for multiple sclerosis: A literature review.
Khodaie F, Abbasi N, Kazemi Motlagh AH, Zhao B, Naser Moghadasi A. Khodaie F, et al. Among authors: naser moghadasi a. Mult Scler Relat Disord. 2022 Apr;60:103715. doi: 10.1016/j.msard.2022.103715. Epub 2022 Feb 26. Mult Scler Relat Disord. 2022. PMID: 35259684 Review.
Neurocinema: A brief overview.
Naser Moghadasi A. Naser Moghadasi A. Iran J Neurol. 2015 Jul 6;14(3):180-4. Iran J Neurol. 2015. PMID: 26622987 Free PMC article.
The hidden link: How oral and respiratory microbiomes affect multiple sclerosis.
Jameie M, Ahli B, Ghadir S, Azami M, Amanollahi M, Ebadi R, Rafati A, Naser Moghadasi A. Jameie M, et al. Among authors: naser moghadasi a. Mult Scler Relat Disord. 2024 Aug;88:105742. doi: 10.1016/j.msard.2024.105742. Epub 2024 Jun 21. Mult Scler Relat Disord. 2024. PMID: 38964239 Review.
149 results